TOLL LIKE RECEPTOR 4 ANTAGONISTS AND USE IN AUTOIMMUNE LIVER DISEASES

• 收藏
• 分享

专利权人:

发明人:

WU EDWIN SC

申请号：

IN201717036909

公开号：

IN201717036909A

申请日:

2017.10.17

申请国别(地区):

IN

年份:

2017

代理人:

摘要：

The present invention relates to new medical uses of morphinans such as naltrexone nalmefene and their related derivatives. The present invention relates to Toll like receptor 4 (TLR4) antagonist compounds and pharmaceutical formulations thereof and use thereof for prevention and treatment of autoimmune liver diseases including but not limited to autoimmune hepatitis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/